Gómez-Bravo, Miguel Angel <br/><br/>
Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.  [electronic resource] 

 -  Journal of clinical pharmacology  Nov 2013 
 - 1146-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-4604 
<br/><br/><label>Standard No.: </label>10.1002/jcph.154  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Cytochrome P-450 CYP3A--genetics<br/>Graft Rejection--genetics<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Liver Transplantation<br/>Polymorphism, Single Nucleotide<br/>Tacrolimus--administration & dosage<br/>Tissue Donors<br/>White People--genetics